Patents by Inventor Mark Kontny

Mark Kontny has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7439397
    Abstract: The compound 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(trifluoromethyl) phenol may be used to prepare the compound (3R)-3-[2-hydroxy-5-(trifluoromethyl)phenyl]-N,N-diisopropyl-N-methyl-3-phenylpropan-1-aminium bromide by reaction with methyl bromide.
    Type: Grant
    Filed: March 8, 2005
    Date of Patent: October 21, 2008
    Assignee: Pfizer Inc
    Inventors: Ivan Richards, Sue K. Cammarata, Craig D. Wegner, Michael Hawley, Mark Peter Warchol, Mark Kontny, Walter Morozowich, Karen Patrice Kolbasa, Malcolm Wilson Moon, Dominique Bonafoux, Sergey Gregory Wolfson, Patrick James Lennon
  • Publication number: 20050148672
    Abstract: The compound 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(trifluoromethyl) phenol may be used to prepare the compound (3R)-3-[2-hydroxy-5-(trifluoromethyl)phenyl]-N,N-diisopropyl-N-methyl-3-phenylpropan-1-aminium bromide by reaction with methyl bromide.
    Type: Application
    Filed: March 8, 2005
    Publication date: July 7, 2005
    Inventors: Ivan Richards, Sue Cammarata, Craig Wegner, Michael Hawley, Mark Warchol, Mark Kontny, Walter Morozowich, Karen Kolbasa, Malcolm Moon, Dominique Bonafoux, Sergey Wolfson, Patrick Lennon
  • Patent number: 6890920
    Abstract: Novel quaternary ammonium compounds of the formula and any stereoisomers thereof, wherein R1, R2 and R3 independently represent C1-C6 alkyl, optionally substituted with phenyl or hydroxyl, or both, and wherein any two of R1, R2 and R3 may form a ring together with the quaternary ammonium nitrogen; R4 represents —H, —CH3, or —CO—R4-1, wherein R4-1 represents —(C1-C4 alkyl), —(C1-C4 alkoxy), or —NR4-2R4-3, wherein R4-2 and R4-3 independently represent —H or —(C1-C4 alkyl); R5, R6 and R7 independently represent —H, —OCH3, —OH, —CONH2, —SO2NH2, —F, —Cl, —Br, —I, —CF3, or —(C1-C4 alkyl), optionally substituted with one or two —OH, —(C1-C4 alkoxy), —COOH, or —CO—O—(C1-C3 alkyl); and X? represents an anion of a pharmaceutically acceptable acid, the compounds for use as medicaments, use of the compounds for the manufacture of specific medicaments, and pharmaceutical compositions comprising the compounds. The present invention also concerns a method of treatment involving administration of the compounds.
    Type: Grant
    Filed: October 25, 2002
    Date of Patent: May 10, 2005
    Assignee: Pharmacia & Upjohn Company
    Inventors: Ivan Richards, Sue K. Cammarata, Craig D. Wegner, Michael Hawley, Mark Peter Warchol, Mark Kontny, Walter Morozowich, Karen Patrice Kolbasa, Malcolm Wilson Moon, Dominique Bonafoux, Sergey Gregory Wolfson, Patrick James Lennon
  • Publication number: 20050043296
    Abstract: A pharmaceutical composition comprising a salt or a crystalline salt in which the salt or crystalline salt comprises an acid of an artificial sweetener and a tricyclic compound is provided. Also provided are methods of making the salt, methods of making the crystalline salt, and methods of treatment of sexual dysfunction using the salt or the crystalline salt.
    Type: Application
    Filed: October 2, 2003
    Publication date: February 24, 2005
    Inventors: Michael Hawley, Mark Kontny, Gordon Halstead
  • Publication number: 20030158176
    Abstract: Novel quaternary ammonium compounds of the formula 1
    Type: Application
    Filed: October 25, 2002
    Publication date: August 21, 2003
    Inventors: Ivan Richards, Sue K. Cammarata, Craig D. Wegner, Michael Hawley, Mark Peter Warchol, Mark Kontny, Walter Morozowich, Karen Patrice Kolbasa, Malcolm Wilson Moon, Dominique Bonafoux, Sergey Gregory Wolfson, Patrick James Lennon